MarketView
RXA MarketView
The tool provides comprehensive analysis for both NHS and pharmaceutical companies of the UK prescribing market, giving valuable insight down to CCG level.
With the RXA MarketView tool you can:
- Analyse up to 5 years of NHS prescribing and other sales data
- See data for all 20,000+ products prescribed by UK GPs, including branded and generic products
- See data for England, Wales, Scotland and Northern Ireland
- Select a range of reporting dimensions and filters
- SHA
- Area/CCG
- GP Practice
- Product
- Brand vs. Generic
- View extensive highly visual tables, charts and maps in the purpose-built dashboard
- Access easy to interpret analytics
- Export all data and graphics for ad-hoc analytics and report building – (E.g. Excel, CSV, jpeg and PDF)
Request your demonstration today
Andrew Norman, Director
I am extremely happy with the model and with the working relationship we have with Inspiremed.
Country Manager UK, Leading Diagnostics Company
Rx Analyser is already having a significant impact on our business, allowing our Territory Managers to focus on established CCG accounts and identify practice level successes and others for further development.
Managing Director, UK Diabetes Healthcare Company
If I had to choose one feature about Rx Analyser it would be the market overview, which gives a great snapshot of the market from practice up to National level.
Sales and Marketing Manager, Leading Healthcare Company, 2016
Inspiremed’s customer service is personal, swift and attentive.
National Sales Manager, UK Pharmaceutical Company
Comprehensive, flexible, efficient and professional. A recent training program for our sales team was both well delivered and received. Any bespoke amends to the tool are quickly implemented in line with our requirements.
Sales and Marketing Manager, Leading Healthcare Company, 2016
Budget impact calculation makes for a much more informed discussion with customers where cost savings are a key driver.
